These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 12640100)
1. Cyclin alterations in giant cell tumor of bone. Kauzman A; Li SQ; Bradley G; Bell RS; Wunder JS; Kandel R Mod Pathol; 2003 Mar; 16(3):210-8. PubMed ID: 12640100 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis. Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500 [TBL] [Abstract][Full Text] [Related]
3. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms. Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405 [TBL] [Abstract][Full Text] [Related]
4. Cyclins D1, D3, E, and A in vulvar carcinoma patients. Knopp S; Bjørge T; Nesland JM; Tropé C; Holm R Gynecol Oncol; 2005 Jun; 97(3):733-9. PubMed ID: 15894358 [TBL] [Abstract][Full Text] [Related]
5. Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma. Flørenes VA; Faye RS; Maelandsmo GM; Nesland JM; Holm R Clin Cancer Res; 2000 Sep; 6(9):3614-20. PubMed ID: 10999753 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377 [TBL] [Abstract][Full Text] [Related]
7. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413 [TBL] [Abstract][Full Text] [Related]
8. Deregulation of D-type cyclins in uterine cancers. Cyclin D1/D3 is differentially expressed in cervical cancer. Skomedal H; Forus A; Holm R Anticancer Res; 2003; 23(5A):3929-35. PubMed ID: 14666699 [TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Weroha SJ; Li SA; Tawfik O; Li JJ Carcinogenesis; 2006 Mar; 27(3):491-8. PubMed ID: 16311245 [TBL] [Abstract][Full Text] [Related]
11. Expression and possible role of cyclin D3 in human pancreatic adenocarcinoma. Ito Y; Takeda T; Wakasa K; Tsujimoto M; Matsuura N Anticancer Res; 2001; 21(2A):1043-8. PubMed ID: 11396138 [TBL] [Abstract][Full Text] [Related]
12. Cyclin D3 immunoreactivity in gastrointestinal stromal tumors is independent of cyclin D3 gene amplification and is associated with nuclear p27 accumulation. Pruneri G; Mazzarol G; Fabris S; Del Curto B; Bertolini F; Neri A; Viale G Mod Pathol; 2003 Sep; 16(9):886-92. PubMed ID: 13679452 [TBL] [Abstract][Full Text] [Related]
13. Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome. Bondi J; Husdal A; Bukholm G; Nesland JM; Bakka A; Bukholm IR J Clin Pathol; 2005 May; 58(5):509-14. PubMed ID: 15858123 [TBL] [Abstract][Full Text] [Related]
14. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
15. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53. Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265 [TBL] [Abstract][Full Text] [Related]
16. Increased cyclin D3 expression significantly correlates with p27 nuclear positivity in gastrointestinal stromal tumors. Draper N; Bui M; Boulware DC; Lloyd M; Chiappori AA; Pledger WJ; Coppola D Hum Pathol; 2008 Dec; 39(12):1784-91. PubMed ID: 18701138 [TBL] [Abstract][Full Text] [Related]
17. Central giant cell granuloma of the jaws: assessment of cell cycle proteins. Kauzman A; Li SQ; Bradley G; Bell RS; Wunder JS; Kandel R J Oral Pathol Med; 2004 Mar; 33(3):170-6. PubMed ID: 15128059 [TBL] [Abstract][Full Text] [Related]
19. beta-Catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: its role in cyclin D1 overexpression and tumor progression. Shiratsuchi H; Nakashima T; Hirakawa N; Toh S; Nakagawa T; Saito T; Tsuneyoshi M; Komune S Head Neck; 2007 Jun; 29(6):577-84. PubMed ID: 17315172 [TBL] [Abstract][Full Text] [Related]
20. Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors. Hibberts NA; Simpson DJ; Bicknell JE; Broome JC; Hoban PR; Clayton RN; Farrell WE Clin Cancer Res; 1999 Aug; 5(8):2133-9. PubMed ID: 10473097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]